Malaria News and Research

Latest Malaria News and Research

Human evolution in genetic fast lane

Countering a common theory that human evolution has slowed to a crawl or even stopped in modern humans, a new study examining data from an international genomics project describes the past 40,000 years as a time of supercharged evolutionary change, driven by exponential population growth and cultural shifts.

10 Dec 2007

Immtech and BioAlliance sign agreement on Pafuramidine for African sleeping sickness

Immtech Pharmaceuticals has announced that the Company has granted an exclusive license to BioAlliance Pharma SA to commercialize Immtech's oral drug, pafuramidine maleate (pafuramidine), in Europe for the treatment of pneumocystis pneumonia (PCP) in AIDS patients and for the treatment of Human African trypanosomiasis, also known as African sleeping sickness.

5 Dec 2007

Switzerland creates new centre for vaccine research

The Institute will develop an immunology, microbiology and vaccine research laboratory platform to encourage cooperation between scientists working in the field of HIV, malaria, tuberculosis, influenza and cancer vaccine development in Switzerland, from fundamental to clinical researchers.

4 Dec 2007

New genetic findings on malaria parasite

The malaria parasite has been studied for decades, but surprisingly, little is known about how it behaves in humans to cause disease.

29 Nov 2007

Bill finds another $200m to beat polio

The fight against polio has had an enormous boost by way of a grant of $200m from Bill Gates and Rotary.

27 Nov 2007

Less drugs may be best for treating malaria

The current dosage of drugs used in treating malaria may be helping the parasites become resistant to the drugs faster, without improving the long-term outcome in patients.

27 Nov 2007

Measures that are needed to curb humanity's most fatal diseases

Several of the world's most eminent health scientists and organizations today publish a landmark global consensus on the 20 foremost measures needed to curb humanity's most fatal diseases, their study featured in Nature magazine.

21 Nov 2007

Super-tiny structures for biomedical research

The University of Massachusetts Amherst is host to a new nanomedicine institute focused on developing super-tiny structures for biomedical research.

19 Nov 2007

Breakthrough innovation for high sensitivity TB and Malaria diagnostics

At this year's 39th World Forum for Medicine in Dusseldorf (MEDICA, November 14-17), Partec, a globally leading developer, manufacturer and provider of dedicated diagnostic solutions in the response to HIV/AIDS, Tuberculosis and Malaria is presenting a breakthrough innovation for high sensitivity TB and Malaria diagnostics in low- and middle-income countries.

15 Nov 2007

Bolivian Amazon study finds using insect repellent between dusk and bedtime makes insecticide-treated bednets more effective

Using insect repellent in addition to insecticide treated bednets (ITNs) has been shown to provide greater protection against malaria in areas where mosquitoes feed in the early evening.

14 Nov 2007

Dengue fever vaccine looks very promising

The vaccine Tetravalent is manufactured by drug company Sanofi who say it will be ready to be submitted for approval by the year 2012.

7 Nov 2007

Plants provide better understanding of the epidemiology and evolution of infectious disease

Animals, like plants, can build tolerance to infections at a genetic level, and these findings could provide a better understanding of the epidemiology and evolution of infectious disease, according to evolutionary biologists.

6 Nov 2007

Remote sensing technology used to predict future pandemics

With the help of 14 satellites currently in orbit and the National Aeronautics and Space Administration's (NASA) Applied Sciences Program, scientists have been able to observe the Earth's environment to help predict and prevent infectious disease outbreaks around the world.

6 Nov 2007

Ugandan President calls for public-private partnership to fight HIV/AIDS during U.S. meeting

Ugandan President Yoweri Museveni last week during a meeting in Washington, D.C., with representatives from the African Diplomatic Corps, U.S. government officials and representatives from the health care industry called for a public-private partnership to fight HIV/AIDS in Uganda, Uganda's Monitor reports.

6 Nov 2007

Immtech receives $5.1 million to tackle trypanosomiasis and leishmania

Immtech Pharmaceuticals, Inc. has announced that it has received $5.1 million from a scientific consortium led by the University of North Carolina at Chapel Hill (UNC), which received funds from The Bill & Melinda Gates Foundation, to develop drugs for fighting African sleeping sickness (trypanosomiasis) and leishmania.

6 Nov 2007

Global Fund, World Bank provide Malawi with $48.5 million to expand HIV/AIDS services, commission says

Malawi's National AIDS Commission in a statement issued Thursday announced that it has received $48.5 million from the Global Fund To Fight AIDS, Tuberculosis and Malaria and the World Bank to expand HIV/AIDS services in the country up to December, Xinhua News Agency reports.

5 Nov 2007

U.N., Google, Cisco Systems launch web site aimed at providing data on Millennium Development Goals

The United Nations, Google and Cisco Systems on Thursday launched a Web site aimed at providing data and information on global efforts to meet the U.N. Millennium Development Goals, the AP/International Herald Tribune reports.

5 Nov 2007

Blood group O may be the key to a cure for malaria

New research from Scotland has led to a discovery which may bring a cure for malaria a step closer.

31 Oct 2007

Clinton signs pledge to commit to fight against HIV/AIDS

Sen. Hillary Rodham Clinton (D-N.Y.), who is running for the Democratic presidential nomination, recently signed a pledge to commit to investing $50 billion by 2013 to fight HIV/AIDS domestically and worldwide, the New York Times reports. Clinton also plans to issue a formal policy on the disease, according to the Times (Seelye, "The Caucus," New York Times, 10/26).

30 Oct 2007

Whole parasite malaria vaccine to be manufactured for clinical trials

Sanaria Inc. and the PATH Malaria Vaccine Initiative has officially opened a one-of-a-kind clinical manufacturing facility to produce a vaccine that uses a weakened form of the malaria parasite to fight a disease that annually kills more than one million people, most of them African children.

29 Oct 2007

Malaria News and Research

Latest Malaria News and Research

Human evolution in genetic fast lane

Immtech and BioAlliance sign agreement on Pafuramidine for African sleeping sickness

Switzerland creates new centre for vaccine research

New genetic findings on malaria parasite

Bill finds another $200m to beat polio

Less drugs may be best for treating malaria

Measures that are needed to curb humanity's most fatal diseases

Super-tiny structures for biomedical research

Breakthrough innovation for high sensitivity TB and Malaria diagnostics

Bolivian Amazon study finds using insect repellent between dusk and bedtime makes insecticide-treated bednets more effective

Dengue fever vaccine looks very promising

Plants provide better understanding of the epidemiology and evolution of infectious disease

Remote sensing technology used to predict future pandemics

Ugandan President calls for public-private partnership to fight HIV/AIDS during U.S. meeting

Immtech receives $5.1 million to tackle trypanosomiasis and leishmania

Global Fund, World Bank provide Malawi with $48.5 million to expand HIV/AIDS services, commission says

U.N., Google, Cisco Systems launch web site aimed at providing data on Millennium Development Goals

Blood group O may be the key to a cure for malaria

Clinton signs pledge to commit to fight against HIV/AIDS

Whole parasite malaria vaccine to be manufactured for clinical trials

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Malaria News and Research

Latest Malaria News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in